Article

7. Treatment of neuroendocrine tumours with high dose 131I-MIBG therapy

Jamshed BomanjiInstitute of Nuclear Medicine, andW. WongMeyerstein Institute of Oncology, The Middlesex Hospital, Mortimer Street, London, UKMark N. GazeMeyerstein Institute of Oncology, The Middlesex Hospital, Mortimer Street, London, UKA.M. CassoniMeyerstein Institute of Oncology, The Middlesex Hospital, Mortimer Street, London, UKWendy A. WaddingtonInstitute of Nuclear Medicine, andJosé SolanoMeyerstein Institute of Oncology, The Middlesex Hospital, Mortimer Street, London, UK

Nuclear Medicine Communicationsjournal2002en

ABI

Abstract

s of the 30th Annual Meeting of the British Nuclear Medicine Society Manchester, UK, 8-10 April 2002. Therapy

Topics

Medical Imaging Techniques and Applications Neuroblastoma Research and Treatments Neuroendocrine Tumor Research Advances

Identifiers

DOI: 10.1097/00006231-200204000-00018

Citations and references

Cited by 00 references

Metrics — AkademScholar · Coming soon